BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 11815495)

  • 41. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).
    Prince CT; Becker DJ; Costacou T; Miller RG; Orchard TJ
    Diabetologia; 2007 Nov; 50(11):2280-8. PubMed ID: 17768606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. One in five laboratories using various hemoglobin A1c methods do not meet the criteria for optimal diabetes care management.
    Lenters-Westra E; Weykamp C; Schindhelm RK; Siebelder C; Bilo HJ; Slingerland RJ
    Diabetes Technol Ther; 2011 Apr; 13(4):429-33. PubMed ID: 21355726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemoglobin Glycosylation Index is not related with blood glucose.
    Merino-Torres JF; Fajardo-Montañana C; Ferrer-García JC; Piñón-Sellés F
    J Diabetes Complications; 2003; 17(5):249-53. PubMed ID: 12954152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L).
    Liberopoulos EN; Florentin M; Kei A; Mountzouri E; Agouridis A; Elisaf MS
    J Clin Hypertens (Greenwich); 2010 Jul; 12(7):543-8. PubMed ID: 20629819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
    Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
    BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control.
    Zhang L; Krzentowski G; Albert A; Lefebvre PJ
    Diabetes Care; 2001 Jul; 24(7):1275-9. PubMed ID: 11423515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study.
    Hutchinson MS; Joakimsen RM; Njølstad I; Schirmer H; Figenschau Y; Jorde R
    J Endocrinol Invest; 2012 Oct; 35(9):835-40. PubMed ID: 22186659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community.
    Martin DD; Shephard MD; Freeman H; Bulsara MK; Jones TW; Davis EA; Maguire GP
    Med J Aust; 2005 May; 182(10):524-7. PubMed ID: 15896181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
    Barnett AH; Burger J; Johns D; Brodows R; Kendall DM; Roberts A; Trautmann ME
    Clin Ther; 2007 Nov; 29(11):2333-48. PubMed ID: 18158075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Strongest correlation of HbA(1c) with 1-month-earlier glucose levels in type 2 diabetes.
    Nakazaki M; Fukushige E; Koriyama N; Fukudome M; Hashiguchi H; Aso K; Yano J; Ikeda Y; Kato K; Tei C
    Diabetes Res Clin Pract; 2004 Mar; 63(3):171-7. PubMed ID: 14757288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
    Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D
    Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between glycemic control and short-term healthcare costs among commercially insured diabetes patients in the United States.
    Aagren M; Luo W
    J Med Econ; 2011; 14(1):108-14. PubMed ID: 21241161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
    Hirsch IB
    Diabetes Care; 2015 Aug; 38(8):1610-4. PubMed ID: 26207054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases.
    Koga M; Kasayama S; Kanehara H; Bando Y
    Diabetes Res Clin Pract; 2008 Aug; 81(2):258-62. PubMed ID: 18513821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability.
    Pickup JC; Kidd J; Burmiston S; Yemane N
    Diabetes Metab Res Rev; 2006; 22(3):232-7. PubMed ID: 16389648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between glycated hemoglobin and glucose concentrations in the adult Galician population: selection of optimal glycated hemoglobin cut-off points as a diagnostic tool of diabetes mellitus.
    Botana López MA; López Ratón M; Tomé MA; Fernández Mariño A; Mato Mato JA; Rego Iraeta A; Pérez Fernández R; Cadarso Suárez C
    Endocrinol Nutr; 2012 Oct; 59(8):496-504. PubMed ID: 22857908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients.
    Davidson J; Koro C; Arondekar B; Lee BH; Fedder D
    Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship between HbA1c and fasting plasma glucose in patients with increased plasma liver enzyme measurements.
    Christiansen R; Rasmussen LM; Nybo H; Steenstrup T; Nybo M
    Diabet Med; 2012 Jun; 29(6):742-7. PubMed ID: 22150572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Utility of casual postprandial glucose levels in type 2 diabetes management.
    El-Kebbi IM; Ziemer DC; Cook CB; Gallina DL; Barnes CS; Phillips LS
    Diabetes Care; 2004 Feb; 27(2):335-9. PubMed ID: 14747210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults.
    Sung KC; Rhee EJ
    Diabet Med; 2007 Aug; 24(8):848-54. PubMed ID: 17650158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.